Thanks @Icebluedenim
As Van1 said, I'm sure the management team will find that of interest. I have been wondering how possible approval for other indications may effect MPL's orphan status for ALS/MND. I'm assuming it will not be a problem. There is a lot to take in, but my initial thoughts are that having multiple uses and balancing it all out is good problem to have.
Cheers
Thanks @Icebluedenim As Van1 said, I'm sure the management team...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.76M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.3¢ | 16.0¢ | $14.13K | 87.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 157942 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 246514 | 7 |
View Market Depth
| Last trade - 15.07pm 10/07/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |